Inactive Instrument
Cann American Corp. Share Price Other OTC
Stocks
CNNA
US13764N2071
Pharmaceuticals
OTC Markets Traded| Market Cap | 1.77M 1.55M 1.47M 1.34M 2.5M 170M 2.52M 17.56M 6.8M 86.71M 6.65M 6.5M 279M | P/E 2022 |
0.12x | P/E 2023 | 0.19x |
|---|---|---|---|---|---|
| Enterprise Value | 2.08M 1.83M 1.73M 1.57M 2.94M 200M 2.96M 20.65M 8M 102M 7.82M 7.65M 328M | EV / Sales 2022 |
-
| EV / Sales 2023 | - |
| Free-Float |
99% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +4.97% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jason Tucker
CEO | Chief Executive Officer | - | 31/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jason Tucker
BRD | Director/Board Member | - | 31/01/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.97% | +24.45% | - | - | 2.95M | |
| +0.13% | +2.69% | +59.53% | +114.96% | 1,053B | |
| +0.20% | +0.37% | +53.50% | +68.98% | 652B | |
| -0.29% | +0.12% | +20.16% | +73.07% | 468B | |
| -0.85% | -0.25% | +38.63% | +44.47% | 351B | |
| +0.71% | +3.26% | +22.46% | +30.30% | 273B | |
| +1.23% | +1.00% | +11.97% | +13.63% | 254B | |
| +2.11% | +9.17% | +48.49% | +54.88% | 220B | |
| +0.83% | +0.03% | +32.78% | +101.21% | 186B | |
| 0.00% | -9.43% | -31.91% | -60.56% | 170B | |
| Average | +0.85% | +0.30% | +28.40% | +48.99% | 403.04B | |
| Weighted average by Cap. | +0.27% | +1.00% | +38.89% | +68.43% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | - | - |
| Net income | 10.54M 9.25M 8.74M 7.96M 14.9M 1.01B 15.01M 105M 40.49M 516M 39.58M 38.72M 1.66B | 3.82M 3.35M 3.17M 2.89M 5.4M 366M 5.44M 37.9M 14.68M 187M 14.35M 14.04M 601M |
| Net Debt | 202K 177K 167K 152K 285K 19.35M 287K 2M 775K 9.88M 758K 741K 31.76M | 311K 273K 258K 235K 440K 29.82M 443K 3.09M 1.19M 15.23M 1.17M 1.14M 48.95M |
Employees
-
Sector
Pharmaceuticals
